ISRCTN23054430已完成未知
Establishing a feasible optimal therapeutic dose using a new methodology for stroke rehabilitation
niversity of East Anglia (UK)0 个研究点目标入组 24 人开始时间: 2014年4月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
- 2017 results in https://www.ncbi.nlm.nih.gov/pubmed/28802774 (added 22/01/2019)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged 18+ years
- •2. Have presence of moderate upper limb paresis/impairment defined as participants able to open and close their paretic hand six times in one minute but unable to do this 25 times in one minute, from starting position of thumb and finger tips close with an extra, extra, light resistance band placed around fingers and thumb
- •3. Able to imitate action with the nonparetic upper limb. This will be assessed by the Research Therapist
- •4. Be discharged from stroke rehabilitation services
排除标准
- •Participant should not receive therapy to improve upper limb motor function
研究者
相似试验
已完成
1 期
A Trial to Determine the Maximum Tolerated Dose and Evaluate the Safety and Pharmacokinetics of Docetaxel-PNP, Polymeric Nanoparticle Formulation of Docetaxel, in Subjects With Advanced Solid MalignanciesAdvanced Solid MalignanciesNCT01103791Samyang Biopharmaceuticals Corporation19
已完成
1 期
A Phase I Study of ECO-4601 in Patients With Advanced CancerTumorsBreast CancerProstate CancerColorectal CancerLung CancerOvarian CancerPancreatic CancerGliomaNCT00338026Thallion Pharmaceuticals26
撤回
2 期
Safety and Efficacy Study of IV Ganaxolone as Adjuvant Therapy for Established Status Epilepticus (ESE)Status EpilepticusNCT05757544Marinus Pharmaceuticals
招募中
不适用
Investigation of the maximum optimal dosage and efficacy of lenalidomide for the treatment of relapsed and refractory multiple myeloma.multiple myelomaJPRN-UMIN000010178Kurume University Hospital Division of Hematology and Oncology38
已完成
不适用
Optimizing the concentration of a cancer-treating drug (bleomycin) in patients undergoing electrochemotherapyBasal cell carcinoma, squamous cell carcinoma, melanoma or metastases of adenocarcinoma of the breast, treated with electrochemotherapyMalignant neoplasm of breastCancerISRCTN74054653Department of Otorhinolaryngology and Cervicofacial Surgery University Medical Centre26